IPP Bureau

PM Modi dedicates 35 oxygen plants to the nation
PM Modi dedicates 35 oxygen plants to the nation

By IPP Bureau - October 07, 2021

Now all districts of the country will have commissioned PSA Oxygen plants

PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel
PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel

By IPP Bureau - October 07, 2021

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus

Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D
Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D

By IPP Bureau - October 06, 2021

The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20

WHO decision on Covaxin approval next week
WHO decision on Covaxin approval next week

By IPP Bureau - October 06, 2021

Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021

IPM growth led by Covid  driven products to taper off in Q2FY22: Nirmal Bang
IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang

By IPP Bureau - October 06, 2021

In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report

Lupin receives tentative approval for Brexpiprazole tablets
Lupin receives tentative approval for Brexpiprazole tablets

By IPP Bureau - October 06, 2021

This product will be manufactured at Lupin’s Pithampur facility In India

EMA authorises booster dose of Moderna’s Spikevax
EMA authorises booster dose of Moderna’s Spikevax

By IPP Bureau - October 06, 2021

A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects

Ayushman Bharat PM-JAY rates revised
Ayushman Bharat PM-JAY rates revised

By IPP Bureau - October 06, 2021

The rates for over 400 procedures were revised

Paediatric healthcare platform Health Basix raises seed fund
Paediatric healthcare platform Health Basix raises seed fund

By IPP Bureau - October 06, 2021

The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

By IPP Bureau - October 06, 2021

A total of 8308 stores are open across India and medicines are priced at affordable rates

Apollo Hospitals launches Centre of Excellence in Critical Care
Apollo Hospitals launches Centre of Excellence in Critical Care

By IPP Bureau - October 06, 2021

The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas

Temasek to buy a stake in Integrace
Temasek to buy a stake in Integrace

By IPP Bureau - October 05, 2021

The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition

Health minister Mandaviya launches i-Drone for vaccine delivery
Health minister Mandaviya launches i-Drone for vaccine delivery

By IPP Bureau - October 05, 2021

This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid

By IPP Bureau - October 05, 2021

The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)

Zuellig Pharma receives EcoVadis Platinum medal for sustainability
Zuellig Pharma receives EcoVadis Platinum medal for sustainability

By IPP Bureau - October 05, 2021

The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme

Latest Stories

Interviews

Packaging